Forte Biosciences, Inc.
NASDAQ:FBRX
Overview | Financials
Company Name | Forte Biosciences, Inc. |
Symbol | FBRX |
Currency | USD |
Price | 7.09 |
Market Cap | 10,352,534 |
Dividend Yield | 0% |
52-week-range | 6.5 - 21.25 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Paul A. Wagner Ph.D. |
Website | https://www.fortebiorx.com |
An error occurred while fetching data.
About Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD